Frame the question
Define the decision, intended outcomes, available information and scope.
Independent life-sciences advisory
Bridging promising
science and
confident decisions.
Drug delivery, product development and technical insight—connected to help you decide what comes next.
From technology assessment to development strategy.
Drug Delivery·Product Development·CMC·Technical Due Diligence·Competitive Intelligence
01 / Our expertise
Complex science.
Practical direction.
Focused advice for the technical decisions that shape a program, a platform or a potential partnership.
Tell us what you’re evaluating01Drug Delivery
Evaluate delivery options against the needs of your molecule, the intended patient experience and the realities of development.
- Platform suitability and feasibility assessments
- Oral biologics, long-acting and other advanced delivery approaches
- Evidence gaps and next-study priorities
The question: Which delivery approach deserves investment?
02Product Development
Turn product goals and available data into a focused formulation and development plan.
- Formulation strategy and developability assessment
- Study design, data interpretation and troubleshooting
- Development roadmaps and technical partner assessment
The question: What should we develop and test next?
03CMC
Connect formulation decisions with process understanding, product quality and manufacturing readiness.
- Drug-product CMC strategy and risk assessment
- Scale-up and technology-transfer planning
- CDMO technical evaluation and development oversight
The question: Can this product be made consistently at the required scale?
04Technical Due Diligence
Examine the evidence behind an asset or technology before a development, licensing or investment commitment.
- Formulation, delivery and manufacturing data review
- Technical red flags and diligence questions
- Recommendations with explicit assumptions and uncertainties
The question: What must be resolved before we commit?
05Competitive Intelligence
Place technologies and development options in context through focused analysis of publicly available evidence.
- Technology landscapes and targeted scouting
- Platform differentiation and evidence benchmarking
- Scientific and partnering developments relevant to your strategy
The question: Where is the opportunity—and what truly differentiates it?
Who we work with
Specialist perspective.
Where you need it.
Biotech & pharma teamsAdditional depth for formulation, delivery and development decisions.
Investors & partnering teamsTechnical scrutiny of assets, platforms and development assumptions.
Consulting firmsSpecialist support within broader diligence and strategy engagements.
02 / Our approach
Start with the decision.
Follow the evidence.
Every engagement begins with a specific question. We connect scientific assessment with the practical choices your team needs to make.
Examine the evidence
Assess the data, challenge assumptions and identify the gaps that matter.
Map the path forward
Deliver a clear recommendation, its limitations and actionable next steps.
Ways to work together
Focused review / Defined project / Ongoing advisory support
03 / Our experts
Scientific depth.
Development perspective.
Complementary experience across advanced delivery, drug-product development, technical evaluation and manufacturing.
PTExpert
Puneet TyagiPhD
Drug delivery · Formulation · Search & Evaluation
Puneet’s experience spans pharmaceutical formulation, advanced drug delivery, CMC and technology evaluation, including work at AstraZeneca. His interests connect the scientific promise of a platform with the evidence needed to advance it.
His technical background includes biologics formulation, long-acting formulations and oral delivery of biologics.
RTExpert
Ruchit TrivediPhD, MBA
Drug-product development · Scale-up · Manufacturing
Ruchit brings experience across formulation and process development, technology transfer and pharmaceutical manufacturing. His background includes oral solid dosage forms, spray-dried dispersions and modified-release technologies.
His perspective connects early development choices with the requirements of clinical and commercial manufacturing.
04 / Publications
Experience reflected
in the literature.
Explore research by Puneet and Ruchit across oral peptide delivery, long-acting formulations, vaccines, nanotherapeutics and ocular delivery—including their co-authored work on oral peptide delivery.
Explore our publications Research papers & an edited bookLet’s discuss your next decision
A promising molecule.
A complex question.
Let’s build the bridge.
Tell us what you’re developing or evaluating, the decision ahead and the expertise you need.